» Articles » PMID: 12196134

Glutamine Repeats: Structural Hypotheses and Neurodegeneration

Overview
Specialty Biochemistry
Date 2002 Aug 28
PMID 12196134
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

A growing number of neurodegenerative diseases are caused by expansion of CAG trinucleotide repeats coding for polyglutamine. The presence of intranuclear inclusions in the affected neuronal cells has suggested a mechanism for pathogenesis based on protein misfolding and aggregation. Detailed understanding of these phenomena is therefore crucial in order to rationalize different phases of the diseases. In the past decade, a few studies have focused on the structural properties of polyglutamine and on the molecular bases of the aggregation process. Most of these studies have been performed on polyglutamine peptides and protein models. Only one report is currently available on the characterization of a full-length polyglutamine protein. The structural hypotheses resulting from these studies are reviewed here.

Citing Articles

The relationship between aggregation and toxicity of polyglutamine-containing ataxin-3 in the intracellular environment of Escherichia coli.

Invernizzi G, Aprile F, Natalello A, Ghisleni A, Penco A, Relini A PLoS One. 2012; 7(12):e51890.

PMID: 23251648 PMC: 3522584. DOI: 10.1371/journal.pone.0051890.


Molecular origin of polyglutamine aggregation in neurodegenerative diseases.

Khare S, Ding F, Gwanmesia K, Dokholyan N PLoS Comput Biol. 2005; 1(3):230-5.

PMID: 16158094 PMC: 1193989. DOI: 10.1371/journal.pcbi.0010030.


TOX defines a conserved subfamily of HMG-box proteins.

OFlaherty E, Kaye J BMC Genomics. 2003; 4(1):13.

PMID: 12697058 PMC: 155677. DOI: 10.1186/1471-2164-4-13.


From Alzheimer to Huntington: why is a structural understanding so difficult?.

Temussi P, Masino L, Pastore A EMBO J. 2003; 22(3):355-61.

PMID: 12554637 PMC: 140729. DOI: 10.1093/emboj/cdg044.